Plain-English translation of NCT06718283 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at specific blood markers (called hematologic indices) in children diagnosed with juvenile systemic lupus erythematosus, a serious condition where the immune system attacks the body's own tissues. Researchers want to understand whether these blood markers can help doctors track how active the disease is and predict whether it might cause lasting damage to organs.
Doctors need better tools to understand how serious a child's lupus is and to predict which children are at risk for long-term organ damage. By studying these blood markers, researchers hope to find simple, reliable ways to monitor disease activity and help guide treatment decisions.
You likely qualify if…
You likely don't qualify if…
As a participant, you would likely have blood tests performed to measure the special markers researchers are studying. Your blood results would then be compared with measures of your disease activity and any long-term damage to see if these markers are useful for tracking your lupus. The study involves 50 children total and is being conducted at Sohag University.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt
Enrollment target
~50 participants
Started
November 2024
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alshimaa H Khalaf
Sohag University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.